Drugs / Scilin®M30
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01338376 Background | Mar 2011 → Mar 2012 | type 2 diabetes mellitus | Chinese Diabetes Society | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ScilinM30 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01338376 ↗ |
| Modality | Protein / enzyme biologic | “30% soluble-70% isophane recombinant insulin” PMID 24279284 ↗ Nov 2013 |
| Route | Other | “started twice daily injections of 30% soluble-70% isophane recombinant insulin” PMID 24279284 ↗ Nov 2013 |